PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, School of Medicine, Tulane University, New Orleans, LA 70112, USA.\', \'Department of Immunology and Microbiology, Tulane University, New Orleans, LA 70118, USA.\', \'Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA.\', \'The Scripps Research Institute, San Diego, CA 92037, USA.\', \'Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.\', \'Department of Pathology, Tulane University School of Medicine, New Orleans, LA 70112, USA.\', \'Zalgen Labs, Germantown, MD 20876, USA.\', \'Department of Pediatrics, Tulane University School of Medicine, New Orleans, LA 70112, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 120210.3390/v13071202
?:doi
?:hasPublicationType
?:journal
  • Viruses
is ?:pmid of
?:pmid
?:pmid
  • 34201591
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.805
?:rankingScore_hIndex
  • 52
is ?:relation_isRelatedTo_publication of
?:title
  • Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all